Impact of amino acid substitutions in hepatitis C virus genotype 1b core region on liver steatosis and glucose tolerance in non-cirrhotic patients without overt diabetes
β Scribed by Yoshio Sumida; Kazuyuki Kanemasa; Tasuku Hara; Yutaka Inada; Kyoko Sakai; Shunsuke Imai; Naohisa Yoshida; Kohichiroh Yasui; Yoshito Itoh; Takeshi Okanoue; Toshikazu Yoshikawa
- Book ID
- 108953961
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 660 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Previous studies provided a direct experimental evidence for the contribution of HCV core protein in the development of insulin resistance (IR), but the clinical impact of HCV core region on IR is still not clear. The present study evaluated the impact of Amino acid (aa) substitutions o
The substitution of amino acid (aa) 70 of arginine for glutamine and/or that of aa91 of leucine for methionine in the core protein in patients infected with hepatitis C virus (HCV) genotype 1b is associated with a poor response to pegylated interferon and ribavirin. Factors influencing these substit
## Abstract Previous studies identified amino acid (aa) substitutions of the hepatitis C virus core region of genotype 1b (HCVβ1b core region) and elevated serum alphaβfetoprotein (AFP) levels as predictors of poor virologic response to pegylated interferon (PEGβIFN) plus ribavirin (RBV), and also
## Abstract It has been reported that genetic polymorphisms near the __IL28B__ gene or amino acid substitutions in hepatitis C virus (HCV) core protein are associated with the clinical outcome of peginterferon (PEGβIFN) and ribavirin combination therapy. The impact of these factors on the pure sens